Related Experiment Videos

[Takayasu arteritis in pediatric patients]

María Martha Katsicas1, Luis Pompozi, Ricardo Russo

  • 1Servicio de Inmunología y Reumatología, Hospital de Pediatría Prof. Juan P. Garrahan, Argentina. mmkatsi@yahoo.com.ar

Archivos Argentinos De Pediatria
|July 5, 2012
PubMed

Insights

Takayasu's arteritis, a rare pediatric vasculitis, presents diverse symptoms like claudication and hypertension. Early diagnosis and treatment are crucial for managing this potentially life-threatening large vessel inflammatory disease.

Area of Science:

  • Pediatric rheumatology
  • Vascular inflammation
  • Autoimmune diseases

Context:

  • Takayasu's arteritis is a significant cause of vasculitis in children, affecting major arteries like the aorta.
  • It is the third most common vasculitis in the pediatric population.
  • Understanding its pediatric manifestations is critical for timely intervention.

Purpose:

  • To detail the clinical features, diagnostic findings, and treatment strategies for pediatric Takayasu's arteritis.
  • To analyze a case series of children diagnosed with this condition.
  • To highlight the diagnostic challenges and therapeutic approaches in pediatric patients.

Summary:

  • Eleven pediatric patients (10 girls, median age 8) with Takayasu's arteritis were studied.
  • Common symptoms included claudication, hypertension, and CNS involvement; elevated ESR, anemia, and thrombocytosis were noted.
  • Vascular imaging revealed stenosis, dilatation, occlusion, and aneurysms, with outcomes ranging from remission to death.

Impact:

  • Takayasu's arteritis can be life-threatening in children, necessitating high clinical suspicion.
  • The study underscores the importance of recognizing varied symptoms for prompt diagnosis.
  • Effective management involves steroids and immunosuppressants, though outcomes vary, emphasizing the need for ongoing research.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...